Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales21 84820 24720 40520 92721 64822 691
Operating income (EBITDA)4 9743 8654 8505 0265 3795 742
Operating profit (EBIT)4 0462 8723 9794 1694 4954 779
Pre-Tax Profit (EBT)2 521-----
Net income2 5762 2844 4231 5663 0183 793
P/E ratio23,730,215,425,717,815,2
EPS ( $ )1,621,492,921,492,152,53
Dividend per Share ( $ )0,640,900,981,041,141,24
Yield1,67%2,00%2,18%2,70%2,96%3,22%
Reference price ( $ )38.3345.0244.9138.4338.4338.43
Announcement Date01/22/2014
12:44pm
01/29/2015
12:45pm
01/28/2016
12:31pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt3 0863 7822 8762 6822 7593 180
Finance------
Operating income (EBITDA)4 9743 8654 8505 0265 3795 742
Leverage
(Debt/EBITDA)
0,62x0,98x0,59x0,53x0,51x0,55x
Capital Expenditure1 1451 0771 1101 1921 2561 280
Book Value Per Share (BVPS)16,3 $14,3 $14,4 $14,0 $14,3 $15,1 $
Cash Flow per Share2,11 $2,41 $1,97 $2,00 $2,65 $3,30 $
Announcement Date01/22/2014
12:44pm
01/29/2015
12:45pm
01/28/2016
12:31pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 56 581 M$ -
Entreprise Value (EV) 59 263 M$ 59 340 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 25,7x 17,8x
Capitalization / Revenue 2,70x 2,61x
EV / Revenue 2,83x 2,74x
EV / EBITDA 11,8x 11,0x
Yield (DPS / Price) 2,70% 2,96%
Price to book (Price / BVPS) 2,75x 2,68x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 19,9% 20,8%
operating Leverage (Delta EBIT / Delta Sales) 1,86x 2,27x
Net Margin (Net Profit / Revenue) 7,48% 13,9%
ROA (Net Profit / Asset) 6,55% 9,70%
ROE (Net Profit / Equities) 14,5% 19,2%
Rate of Dividend 69,3% 52,8%
Balance Sheet Analysis 2016e 2017e
CAPEX / CA   5,70% 5,80%
Cash Flow / Sales 14,1% 18,0%
Capital Intensity (Assets / Sales) 1,14x 1,44x
Financial Leverage (Net Debt / EBITDA) 0,53x 0,51x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend